Loading...
Early anti IL-1 treatment replaces steroids in refractory Kawasaki disease: clinical experience from two case reports
Refractory Kawasaki disease (KD) is related to a major risk of coronary arteries abnormalities and its treatment is not standardized. In this regard, anakinra (ANA), an interleukin (IL)-1 receptor antagonist, represents an emerging therapeutic option. We report two cases of children, diagnosed with...
Saved in:
| Published in: | Ther Adv Musculoskelet Dis |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8010843/ https://ncbi.nlm.nih.gov/pubmed/33854568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X211002593 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|